13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q2 2023 · Filed May 12, 2023 · Accession 0000902664-23-003015
Total Value
$88.4M
Positions
14
Other Managers
0
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 6,950,000 | $30.1M | 34.03% |
| 2 | ROCKET PHARMACEUTICALS INC | RCKTW | 722,080 | $12.4M | 13.99% |
| 3 | INVIVYD INC | IVVD | 9,248,250 | $11.1M | 12.55% |
| 4 | TG THERAPEUTICS INC | TGTX | 339,500 | $5.1M | 5.77% |
| 5 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 197,700 | $5.1M | 5.75% |
| 6 | BRIDGEBIO PHARMA INC | BBIO | 304,700 | $5.1M | 5.71% |
| 7 | IONIS PHARMACEUTICALS INC | IONS | 126,300 | $4.5M | 5.10% |
| 8 | STOKE THERAPEUTICS INC | STOK | 532,890 | $4.4M | 5.02% |
| 9 | PROQR THRAPEUTICS N V | N71542109 | 1,910,600 | $4.1M | 4.60% |
| 10 | CURIS INC | CRIS | 4,482,142 | $2.7M | 3.02% |
| 11 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $1.7M | 1.94% |
| 12 | ATARA BIOTHERAPEUTICS INC | ATRA | 439,300 | $1.3M | 1.44% |
| 13 | SILENCE THERAPEUTICS PLC | SLNCF | 145,900 | $904,580 | 1.02% |
| 14 | NEXIMMUNE INC | 65344D109 | 133,442 | $50,708 | 0.06% |